Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jens Richardt Moellegaard Jepsen

Biographic Data

ID7443989
NAMEJens Richardt Moellegaard Jepsen
GIVEN NAMESJens Richardt Moellegaard
FAMILY NAMEJepsen
SIGNATUREJEPSEN J R M
AFFILIATIONSCopenhagen University Hospital
ORCID0000-0002-5849-5996
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Clozapine and tuberculosis treatment

    Open Access•Neel Swamy, Jens Richardt Moellegaard Jepsen et al.•ARTICLE•Frontiers in Psychiatry•2025

    Our case supports previous reports that ATT can influence clozapine levels. Clozapine dose adjustments will likely be required to maintain clinical stability and prevent adverse effects, but the management appears to be patient-specific. We recommend closely monitoring patients' clinical status and clozapine levels during and after ATT to optimize outcomes

  • Fish Oil Supplementation in Pregnancy and Neurodevelopment in Childhood—A Randomized Clinical Trial

    Open Access•Laerke Sass, Elín Bjarnadóttir et al.•ARTICLE•Child Development•2021

    A double-blind randomized controlled trial of n-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation or matching placebo during third trimester of pregnancy was conducted within the COPSAC2010 mother-child cohort consisting of 736 women and their children. The objective was to determine if maternal n-3 LCPUFA pregnancy supplementation affects offspring neurodevelopment until 6 years. Neurodevelopment was evaluated in 654 children …

  • No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial

    Open Access•Tina Dam Kristensen, Bjørn H Ebdrup et al.•ARTICLE•Frontiers in Psychiatry•2020

    ClinicalTrials.gov, identifier NCT02098408

  • The Danish High Risk and Resilience Study—VIA 11

    Open Access•Anne Amalie Elgaard Thorup, Nicoline Hemager et al.•ARTICLE•Frontiers in Psychiatry•2018

    Introduction: Offspring of parents with severe mental illness have an increased risk of developing mental illnesses themselves. Familial high risk cohorts give a unique opportunity for studying the development over time, both the illness that the individual is predisposed for and any other diagnoses. These studies can also increase our knowledge of etiology of severe mental illness and provide knowledge about the underlying mechanisms before illn…

No prominent works on this page.

  • The Danish High Risk and Resilience Study—VIA 11

    Open Access•Anne Amalie Elgaard Thorup, Nicoline Hemager et al.•ARTICLE•Frontiers in Psychiatry•2018

    Introduction: Offspring of parents with severe mental illness have an increased risk of developing mental illnesses themselves. Familial high risk cohorts give a unique opportunity for studying the development over time, both the illness that the individual is predisposed for and any other diagnoses. These studies can also increase our knowledge of etiology of severe mental illness and provide knowledge about the underlying mechanisms before illn…

  • No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial

    Open Access•Tina Dam Kristensen, Bjørn H Ebdrup et al.•ARTICLE•Frontiers in Psychiatry•2020

    ClinicalTrials.gov, identifier NCT02098408

  • Fish Oil Supplementation in Pregnancy and Neurodevelopment in Childhood—A Randomized Clinical Trial

    Open Access•Laerke Sass, Elín Bjarnadóttir et al.•ARTICLE•Child Development•2021

    A double-blind randomized controlled trial of n-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation or matching placebo during third trimester of pregnancy was conducted within the COPSAC2010 mother-child cohort consisting of 736 women and their children. The objective was to determine if maternal n-3 LCPUFA pregnancy supplementation affects offspring neurodevelopment until 6 years. Neurodevelopment was evaluated in 654 children …

  • Clozapine and tuberculosis treatment

    Open Access•Neel Swamy, Jens Richardt Moellegaard Jepsen et al.•ARTICLE•Frontiers in Psychiatry•2025

    Our case supports previous reports that ATT can influence clozapine levels. Clozapine dose adjustments will likely be required to maintain clinical stability and prevent adverse effects, but the management appears to be patient-specific. We recommend closely monitoring patients' clinical status and clozapine levels during and after ATT to optimize outcomes

Medicine (4 works) · Psychiatry (4 works) · Psychology (4 works) · Cognition (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Internal Medicine (2 works) · Pediatrics (2 works) · Randomized controlled trial (2 works) · Schizophrenia (object-oriented programming (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae